Evidence map›Paper›PMID 33889420›Full record

ArticleMultiple sclerosis journal - experimental, translational and clinical

Virtual reality is a feasible intervention platform in multiple sclerosis: A pilot protocol and acute improvements in affect.

Michael T Shaw, Maria J Palmeri, Martin Malik, Bryan Dobbs, Leigh E Charvet

Abstract read
In one paragraph

Article in Multiple sclerosis journal - experimental, translational and clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael T ShawDepartment of Neurology, New York University Langone Health, New York, NY, USA.
Maria J PalmeriDepartment of Neurology, New York University Langone Health, New York, NY, USA.
Martin MalikDepartment of Neurology, New York University Langone Health, New York, NY, USA.
Bryan DobbsUniversity of North Carolina School of Medicine, NC, USA.
Leigh E CharvetDepartment of Neurology, New York University Langone Health, New York, NY, USA.ORCID https://orcid.org/0000-0003-4429-9713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople living with multiple sclerosis (MS) experience a high symptom burden that interferes with daily functioning. Virtual reality (VR) is an emerging technology with a range of potential therapeutic applications that may include ameliorating the experience of some common MS symptoms.

objectiveWe tested the feasibility and tolerability of a VR intervention and its preliminary effects on affect.

methodsParticipants with MS were recruited to complete a pilot study of eight sessions of VR over four weeks.

resultsA total of

conclusionVR interventions are feasible, safe, and tolerable for individuals living with MS and may improve affect.

Indexed as

affectmoodmultiple sclerosisneurorehabilitationsymptom managementVirtual realityVR

Identifiers

PMID33889420
PMCPMC8040379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.